Specifically, we show that tumour‐associated myeloid cells exhibit a 12‐fold increase in Mpo expression during the early stages of tumour development, which then decreases to almost fivefold at end‐point, where we observed the highest number of MDSC accumulation. Here, MPO is linked to neoplasm.